Presence of Tumor-Infiltrating Lymphocytes and a Dominant Nodule Within Primary Melanoma Are Prognostic Factors for Relapse-Free Survival of Patients With Thick (T4) Primary Melanoma-Reference-Cited by-同舟云学术

Presence of Tumor-Infiltrating Lymphocytes and a Dominant Nodule Within Primary Melanoma Are Prognostic Factors for Relapse-Free Survival of Patients With Thick (T4) Primary Melanoma

Published:2010-04 Issue:4 Volume:133 Page:646-653
ISSN:0002-9173
Container-title:American Journal of Clinical Pathology
language:en
Short-container-title:Am J Clin Pathol

Author:

Rao Uma N. M.,Lee Sandra J.,Luo Weixiu,Mihm Martin C.,Kirkwood John M.

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/ajcp/article-pdf/133/4/646/4993119/ajcpath133-0646.pdf

Reference33 articles.

1. Balch CM Soong SJ Greshenwald JE Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001;19:3622–3634.

2. Clark WH Elder DE Guerry D A model for predicting survival in stage 1 melanoma based upon tumor progression. J Natl Cancer Inst. 1981;81:1893–1904.

3. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma

4. Tumor-Infiltrating Lymphocytes Predict Sentinel Lymph Node Positivity in Patients With Cutaneous Melanoma

5. Histologic Classification of Tumor-Infiltrating Lymphocytes in Primary Cutaneous Malignant Melanoma

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of tumor-infiltrating lymphocytes in melanoma prognosis and treatment strategies: A systematic review and meta-analysis;Heliyon;2024-06

2. HEV-associated dendritic cells are observed in metastatic tumor-draining lymph nodes of cutaneous melanoma patients with longer distant metastasis-free survival after adjuvant immunotherapy;Frontiers in Immunology;2023-08-25

3. Clinical and biomarker analyses of sintilimab plus gemcitabine and cisplatin as first-line treatment for patients with advanced biliary tract cancer;Nature Communications;2023-03-11

4. Canine melanoma: A review of diagnostics and comparative mechanisms of disease and immunotolerance in the era of the immunotherapies;Frontiers in Veterinary Science;2023-01-06

5. A phase II single arm study of Nivolumab with stereotactic Ablative radiation Therapy after induction chemotherapy in CHOlangiocarcinoma (NATCHO);BMC Cancer;2022-12-12